dextrothyroxine has been researched along with Leukemia, Lymphocytic, Chronic, B-Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aranda-Aguirre, E; Guerrero-Wooley, R; Li, W; Palavecino, E; Wilkin, A | 1 |
| Kazemzadeh, H; Kia, EB; Meamar, AR; Mirhendi, H; Nilforoushan, MR; Rahimi, HR; Talebi, A; Zahabiun, F | 1 |
2 other study(ies) available for dextrothyroxine and Leukemia, Lymphocytic, Chronic, B-Cell
| Article | Year |
|---|---|
Case Report:
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents, Immunological; Antiparasitic Agents; Bacteremia; Fatal Outcome; Humans; Immunocompromised Host; Ivermectin; Klebsiella pneumoniae; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Penicillanic Acid; Piperacillin; Rituximab; Strongyloides stercoralis; Strongyloidiasis; Tazobactam | 2017 |
A case of fatal strongyloidiasis in a patient with chronic lymphocytic leukemia and molecular characterization of the isolate.
Topics: Aged; Albendazole; Animals; Anthelmintics; Fatal Outcome; Humans; Ivermectin; Larva; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Strongyloides stercoralis; Strongyloidiasis | 2008 |